Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00328575 · ClinicalTrials.gov registry record · Phase 1

Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases

A Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target

NCT00328575: Completed Phase 1 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

NCT00328575 is a Phase 1 study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00328575, a Phase 1 study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to determine if using intensity modulated radiation therapy for brain metastases is safe and will improve local control more than standard whole brain radiation therapy.

Primary Outcome

The primary endpoint is the frequency of patients developing unacceptable acute CNS toxicity.

Interventions

  • RADIATION Intensity-Modulated Radiotherapy (IMRT)

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2005-10
Est. Completion 2011-06
Phase Phase 1

What the finished NCT00328575 record still lists

NCT00328575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Intensity-Modulated Radiotherapy (IMRT) is the first listed.

NCT00328575 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00328575 about?

NCT00328575 is a clinical study titled "Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases". The purpose of this study is to determine if using intensity modulated radiation therapy for brain metastases is safe and will improve local control more than standard whole brain radiation therapy.

What is the current status of trial NCT00328575?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-10. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00328575?

The interventions under investigation include: Intensity-Modulated Radiotherapy (IMRT) (RADIATION).

Who is sponsoring clinical trial NCT00328575?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00328575's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00328575, the US trial registry maintained by the National Library of Medicine. NCT00328575 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.